SynBiotic SE (DUSE:SBX)

Germany · Delayed Price · Currency is EUR

1.148

-0.112 (-8.89%)

At close: Jul 3, 2026

SynBiotic SE Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Assets

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	0.54	0.09	0.97	3.2	5.99
Short-Term Investments	0.15	1.98	1.35	0.07	0.05
Cash & Short-Term Investments	0.69	2.07	2.31	3.27	6.04
Cash Growth	-66.63%	-10.61%	-29.25%	-45.88%	45506.65%
Other Receivables	1.01	0.57	0.49	0.84	0.92
Receivables	2.84	1.29	1.21	2.64	0.92
Inventory	2.92	2.76	3.4	3.47	0.55
Other Current Assets	0.42	0.41	1.12	1.21	0.18
Total Current Assets	6.87	6.53	8.05	10.59	7.69
Property, Plant & Equipment	5.02	4.89	5.42	5.86	0.02
Long-Term Investments	1.15	0.33	0.01	0.92	0.68
Goodwill	26.61	-21.6	24.39	39.29	24.24
Other Intangible Assets	4.64	44.57	2.59	3.52	2.39
Long-Term Deferred Tax Assets	0.01	0.06	0.04	0.06	-
Other Long-Term Assets	1.4	0.14	0.13	0.14	-
Total Assets	45.71	34.92	40.62	60.65	35.03

Liabilities

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Accounts Payable	6.32	2.36	1.97	2.21	0.67
Accrued Expenses	0.2	0.05	0.07	0.04	-
Short-Term Debt	-	0.46	1.47	0.06	0.11
Current Portion of Long-Term Debt	0.52	0.14	0.22	-	-
Current Portion of Leases	0.33	0.19	0.24	0.24	-
Current Income Taxes Payable	0	0	0.05	0.11	0.03
Other Current Liabilities	8.08	4.82	1.71	2.32	8.39
Total Current Liabilities	15.45	8.02	5.74	4.97	9.21
Long-Term Debt	1.48	2.56	3.08	2.49	0.25
Long-Term Leases	0.31	0.33	0.47	0.7	-
Long-Term Deferred Tax Liabilities	-	0.03	0.13	0.34	0.07
Other Long-Term Liabilities	7.46	8.65	8.42	15.42	-
Total Liabilities	24.7	19.59	17.83	23.92	9.53

Shareholders' Equity

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Common Stock	6.82	5	4.52	3.67	2.63
Retained Earnings	-58.37	-48.61	-37.98	-13.61	-0.89
Comprehensive Income & Other	74.41	59.4	56.06	44.94	23.75
Total Common Equity	22.87	15.79	22.59	35	25.49
Minority Interest	-1.86	-0.46	0.2	1.72	0.01
Shareholders' Equity	21.01	15.33	22.79	36.72	25.5
Total Liabilities & Equity	45.71	34.92	40.62	60.65	35.03

Additional Metrics

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Total Debt	2.64	3.68	5.48	3.48	0.37
Net Cash (Debt)	-1.95	-1.61	-3.17	-0.21	5.68
Net Cash Growth	-	-	-	-	42737.50%
Net Cash Per Share	-0.33	-0.34	-0.78	-0.07	3.63
Filing Date Shares Outstanding	6.82	5	4.52	3.67	1.56
Total Common Shares Outstanding	6.82	5	4.52	3.67	1.56
Working Capital	-8.58	-1.49	2.31	5.61	-1.52
Book Value Per Share	3.35	3.15	5.00	9.53	16.32
Tangible Book Value	-8.38	-7.18	-4.39	-7.82	-1.15
Tangible Book Value Per Share	-1.23	-1.43	-0.97	-2.13	-0.74